产后抑郁症治疗的最新进展:苏拉诺
Dogancan Sonmez1, Cicek Hocaoglu2
1Rize State Hospital, Clinic of Psychiatry, Rize, Türkiye.
The Eurasian journal of medicine
|December 10, 2024
概括
产后抑郁症 (PPD) 影响了许多母亲,其症状包括情绪变化和内. 这篇评论检查了祖兰,一种新的FDA批准的口服药物用于PPD治疗.
科学领域:
- 生殖精神病学是一种精神病学.
- 围产期心理健康 围产期心理健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 怀孕涉及显著的生理,心理和社会变化.
- 围产期精神疾病,如产后抑郁症 (PPD),很常见,对母亲和婴儿构成风险.
- 经产后抑郁症是一种周周开始的大型抑郁症,发生率高,病因复杂.
研究的目的:
- 审查最近的发展和FDA批准的产后抑郁症治疗方法.
- 分析口服祖拉诺的最新研究,一种新的FDA批准的治疗PPD的药物.
主要方法:
- 关于产后抑郁症治疗的当前研究的文献综述.
- 对临床数据和研究结果的分析与祖拉诺的疗效和安全有关.
主要成果:
- PPD表现出包括抑郁情绪,无情感,内,易怒和认知/身体变化的症状.
- 已建立的治疗方法包括SSRI,SNRI,TCA,荷尔蒙疗法,心理治疗和ECT.
- 口服祖拉诺是最新获得FDA批准的治疗PPD的药物.
结论:
- 产后抑郁症是一个重要的孕产妇健康问题,需要有效的治疗.
- 有一系列的治疗选择存在,而祖拉诺代表了最近的进步.
- 对祖拉诺的进一步研究将阐明它在治疗PPD中的作用.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
01:26Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
01:24Mania and Antimanic Drugs: Overview
135
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
135
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231